These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10716065)

  • 21. Pharmacokinetics of primidone and its active metabolites in the dog.
    Frey HH; Göbel W; Löscher W
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):14-30. PubMed ID: 543743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between primidone, carbamazepine, and nicotinamide.
    Bourgeois BF; Dodson WE; Ferrendelli JA
    Neurology; 1982 Oct; 32(10):1122-26. PubMed ID: 6214728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylethylmalonamide serum levels in patients treated with primidone and the effects of other antiepileptic drugs.
    Streete JM; Berry DJ; Pettit LI; Newbery JE
    Ther Drug Monit; 1986; 8(2):161-5. PubMed ID: 3088778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylethylmalonamide (PEMA). An important metabolite of primidone.
    Baumel IP; Gallagher BB; Mattson RH
    Arch Neurol; 1972 Jul; 27(1):34-41. PubMed ID: 4626105
    [No Abstract]   [Full Text] [Related]  

  • 25. Microassay for primidone and its metabolites phenylethylmalondiamide, phenobarbital and p-hydroxyphenobarbital in human serum, saliva, breast milk and tissues by gas chromatography--mass spectrometry using selected ion monitoring.
    Nau H; Jesdinsky D; Wittfoht W
    J Chromatogr; 1980 Apr; 182(1):71-9. PubMed ID: 7380904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetazolamide-induced interference with primidone absorption. Case reports and metabolic studies.
    Syversen GB; Morgan JP; Weintraub M; Myers GJ
    Arch Neurol; 1977 Feb; 34(2):80-4. PubMed ID: 836189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition of primidone, phenylethylmalonamide, and phenobarbital in the rabbit.
    Hunt RJ; Miller KW
    Drug Metab Dispos; 1978; 6(1):75-81. PubMed ID: 23277
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat.
    Doheny HC; Ratnaraj N; Whittington MA; Jefferys JG; Patsalos PN
    Epilepsy Res; 1999 Apr; 34(2-3):161-8. PubMed ID: 10210031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid as an inhibitor of primidone metabolism.
    Sutton G; Kupferberg HJ
    Neurology; 1975 Dec; 25(12):1179-81. PubMed ID: 812007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous high performance liquid-chromatographic determination of carbamazepine, carbamazepine-10,11-epoxide, ethosuximide, phenobarbital, phenytoin, primidone and phenylethylmalonamide in plasma.
    Neels HM; Totté JA; Verkerk RM; Vlietinck AJ; Scharpé SL
    J Clin Chem Clin Biochem; 1983 May; 21(5):295-9. PubMed ID: 6875477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primidone and phenobarbital during lactation period in epileptic women: total and free drug serum levels in the nursed infants and their effects on neonatal behavior.
    Kuhnz W; Koch S; Helge H; Nau H
    Dev Pharmacol Ther; 1988; 11(3):147-54. PubMed ID: 3383727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin.
    Lolin YI; Ratnaraj N; Hjelm M; Patsalos PN
    Epilepsy Res; 1994 Oct; 19(2):99-110. PubMed ID: 7843173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous determination of primidone and its three major metabolites in rat urine by high-performance liquid chromatography using solid-phase extraction.
    Ferranti V; Chabenat C; Ménager S; Lafont O
    J Chromatogr B Biomed Sci Appl; 1998 Oct; 718(1):199-204. PubMed ID: 9832377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Oct; 29(4):257-86. PubMed ID: 8549027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of vigabatrin in rat blood and cerebrospinal fluid.
    Tong X; Ratnaraj N; Patsalos PN
    Seizure; 2007 Jan; 16(1):43-9. PubMed ID: 17118677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primidone, phenobarbital, and PEMA: I. Seizure protection, neurotoxicity, and therapeutic index of individual compounds in mice.
    Bourgeois BF; Dodson WE; Ferrendelli JA
    Neurology; 1983 Mar; 33(3):283-90. PubMed ID: 6681871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration.
    Pisani F; Richens A
    Clin Pharmacokinet; 1983; 8(3):272-6. PubMed ID: 6851372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs.
    Cottrell PR; Streete JM; Berry DJ; Schäfer H; Pisani F; Perucca E; Richens A
    Epilepsia; 1982 Jun; 23(3):307-13. PubMed ID: 7084140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primidone, phenobarbital, and PEMA: II. Seizure protection, neurotoxicity, and therapeutic index of varying combinations in mice.
    Bourgeois BF; Dodson WE; Ferrendelli JA
    Neurology; 1983 Mar; 33(3):291-5. PubMed ID: 6681872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.